The Enterprise Value as of December 2025 (TTM) for Voyager Therapeutics, Inc. (VYGR) is 235.09M

According to Voyager Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 235.09M. This represents a change of 3.10% compared to the average of 228.03M of the last 4 quarters.

Voyager Therapeutics, Inc. (VYGR) Historical Enterprise Value (quarterly & annually)

How has VYGR Enterprise Value performed in the past?

The mean historical Enterprise Value of Voyager Therapeutics, Inc. over the last ten years is 247.26M. The current 235.09M Enterprise Value has changed 9.41% with respect to the historical average. Over the past ten years (40 quarters), VYGR's Enterprise Value was at its highest in in the June 2019 quarter at 977.74M. The Enterprise Value was at its lowest in in the December 2021 quarter at 29.20M.

Voyager Therapeutics, Inc. (VYGR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Voyager Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Voyager Therapeutics, Inc. (VYGR) Average Enterprise Value

How has VYGR Enterprise Value performed in the past?

The current Enterprise Value of Voyager Therapeutics, Inc. (VYGR) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Voyager Therapeutics, Inc. (VYGR) Enterprise Value vs. Peers

How is VYGR’s Enterprise Value compared to its peers?

Voyager Therapeutics, Inc.’s Enterprise Value is greater than Atea Pharmaceuticals, Inc. (154.94M), less than Entrada Therapeutics, Inc. (347.42M), greater than Humacyte, Inc. (196.00M), greater than Arcturus Therapeutics Holdings Inc. (26.78M), less than Vanda Pharmaceuticals Inc. (243.49M), less than Pyxis Oncology, Inc. (279.07M), greater than Achieve Life Sciences, Inc. (232.44M), less than Enanta Pharmaceuticals, Inc. (469.35M), less than Allogene Therapeutics, Inc. (362.93M), greater than Sagimet Biosciences Inc. (164.48M),

Build a custom stock screener for Voyager Therapeutics, Inc. (VYGR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Voyager Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Voyager Therapeutics, Inc. (VYGR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Voyager Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.